Markus Kaller
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 5%
- Cancer Cells and Metastasis
- Cytokine Signaling Pathways and Interactions
Papers in
-
- RNA modifications and cancer 10
- RNA Research and Splicing 6
- Genomics and Chromatin Dynamics 4
-
- MicroRNA in disease regulation 9
- Cancer-related molecular mechanisms research 9
- Co-authors
- Heiko Hermeking (22 shared papers)René Jackstadt (5 shared papers)Helge Siemens (4 shared papers)Sabine Hünten (4 shared papers)Matjaž Rokavec (5 shared papers)David Horst (6 shared papers)Antje Menssen (2 shared papers)Meryem Gülfem Öner (2 shared papers)
- Journals
- Cancers (3 papers)Advances in experimental medicine and biology (3 papers)Eukaryotic Cell (2 papers)Oncotarget (2 papers)Molecular & Cellular Proteomics (2 papers)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Markus Kaller
26 papers receiving 2.0k citations
Markus Kaller's Hit Papers
Peers
Comparison fields: 5 of 90
- Cancer Research 1.0k
- Oncology 579
- Molecular Biology 1.3k
- Immunology 197
- Cell Biology 129
Countries citing papers authored by Markus Kaller
This map shows the geographic impact of Markus Kaller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Kaller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Kaller more than expected).
Fields of papers citing papers by Markus Kaller
This network shows the impact of papers produced by Markus Kaller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Kaller. The network helps show where Markus Kaller may publish in the future.
Co-authors
The 25 scholars most cited alongside Markus Kaller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis Hit paper breakdown → | 2014 | 631 |
| 2 | miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions Hit paper breakdown → | 2011 | 504 |
| 3 | 2011 | 178 | |
| 4 | 2013 | 125 | |
| 5 | 2017 | 78 | |
| 6 | 2020 | 74 | |
| 7 | 2012 | 63 | |
| 8 | 2015 | 58 | |
| 9 | 2018 | 40 | |
| 10 | 2018 | 38 | |
| 11 | 2022 | 36 | |
| 12 | 2006 | 33 | |
| 13 | 2016 | 31 | |
| 14 | 2006 | 30 | |
| 15 | 2008 | 28 | |
| 16 | 2023 | 27 | |
| 17 | 2017 | 19 | |
| 18 | 2020 | 17 | |
| 19 | 2018 | 16 | |
| 20 | 2006 | 8 |
About Markus Kaller
Markus Kaller is a scholar working on Molecular Biology, Cancer Research, Oncology, Plant Science and Cell Biology, having authored 29 papers that have together received 2.1k indexed citations. Recurring topics across this work include RNA modifications and cancer (10 papers), MicroRNA in disease regulation (9 papers), Cancer-related molecular mechanisms research (9 papers), Cancer Cells and Metastasis (6 papers), RNA Research and Splicing (6 papers), Genomics and Chromatin Dynamics (4 papers), Chromosomal and Genetic Variations (3 papers) and Plant Molecular Biology Research (2 papers). The work is most often cited by research in Cancer Research (1.0k citations), Oncology (579 citations), Molecular Biology (1.3k citations), Immunology (197 citations) and Cell Biology (129 citations). Markus Kaller has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Heiko Hermeking, René Jackstadt, Helge Siemens, Sabine Hünten, Matjaž Rokavec, David Horst, Antje Menssen, Meryem Gülfem Öner, Sarah Schwitalla and Florian R. Greten. Their work appears in journals such as Cancers, Advances in experimental medicine and biology, Eukaryotic Cell, Oncotarget and Molecular & Cellular Proteomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.